ULTRAVATE

This brand name is authorized in United States. It is also authorized in Canada.

Active ingredients

The drug ULTRAVATE contains one active pharmaceutical ingredient (API):

1	Ulobetasol UNII 91A0K1TY3Z - HALOBETASOL PROPIONATE
	Ulobetasol is a corticosteroid used for for the topical treatment of plaque psoriasis. Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in plaque psoriasis is unknown.
	Read more about Ulobetasol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ULTRAVATE Lotion	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AC21	Ulobetasol	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	01962701, 01962728
US	FDA, National Drug Code	10631-122